Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.64 |
| ▸ | GSK3B | P49841 | 1/20 | 0.63 |
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | MAOB | P27338 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 4/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.51 |
| ▸ | NPC1 | O15118 | 2/20 | 0.51 |
| ▸ | RAB9A | P51151 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.50 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.50 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.50 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2321900 | 0.94 | SMN1; SMN2 (0.60) | SMN1; SMN2GSK3BMEN1KMT2AMAOB | |
| SCHEMBL8522837 | 0.92 | SMN1; SMN2 (0.57) | SMN1; SMN2GSK3BMEN1KMT2AMAOB | |
| SCHEMBL15822437 | 0.89 | GSK3B (0.55) | SMN1; SMN2GSK3BMEN1KMT2AMAOB | |
| SCHEMBL3495303 | 0.86 | KMO (0.68) | SMN1; SMN2MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL5633848 | 0.85 | GSK3B (0.60) | SMN1; SMN2GSK3BMEN1KMT2AMAPT | |
| SCHEMBL25803089 | 0.84 | GSK3B (0.67) | SMN1; SMN2GSK3BMEN1KMT2AMAOB | |
| SCHEMBL15548441 | 0.84 | SMN1; SMN2 (0.48) | SMN1; SMN2GSK3BMEN1KMT2AMAOB | |
| SCHEMBL14817804 | 0.84 | NPC1 (0.65) | SMN1; SMN2MEN1KMT2AMAPTL3MBTL1 | |
| SCHEMBL12319792 | 0.81 | MEN1 (0.67) | MEN1KMT2ANPC1RAB9A | |
| SCHEMBL3318066 | 0.81 | USP2 (0.60) | SMN1; SMN2GSK3BMEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 500 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3861039-B1 | HYDROGEL COMPOSITIONS | OPHTALMIC CIE (FR) | 2023-11-01 | — | — | EP | claimed |
| US-20210332174-A1 | HYDROGEL COMPOSITIONS | OPHTALMIC COMPAGNIE (FR) | 2021-10-28 | — | — | US | claimed |
| EP-3861039-A1 | HYDROGEL COMPOSITIONS | Ophtalmic Compagnie (FR) | 2021-08-11 | — | — | EP | claimed |
| CN-113166340-A | Hydrogel composition | 眼科公司 | 2021-07-23 | — | — | CN | claimed |
| WO-2020070423-A1 | HYDROGEL COMPOSITIONS | OPHTALMIC COMPAGNIE (FR) | 2020-04-09 | — | — | WO | claimed |
| US-20110123721-A1 | ENZYMATIC SYNTHESIS OF POLYOL ACRYLATES | BASF AKTIENGESELLSCHAFT (DE) | 2011-05-26 | — | — | US | claimed |
| US-12559631-B2 | Thermally curable two-component coating compounds | BASF SE (DE) | 2026-02-24 | — | — | US | disclosed |
| US-20250368830-A1 | METHOD FOR TRANSFERRING AN EMBOSSED STRUCTURE TO THE SURFACE OF A COATING, AND COMPOSITE EMPLOYABLE AS EMBOSSING MOLD | BASF COATINGS GMBH (DE) | 2025-12-04 | — | — | US | disclosed |
| EP-3094493-B2 | LAYERED BUILDING BOARD FOR INSIDE AND OUTSIDE | KRONOPLUS TECHNICAL AG (CH) | 2025-09-03 | — | — | EP | disclosed |
| US-12386253-B2 | Method for transferring an embossed structure to the surface of a coating, and composite employable as embossing mold | BASF COATINGS GMBH (DE) | 2025-08-12 | — | — | US | disclosed |
| US-20250215122-A1 | CURABLE COMPOSITION FOR 3D PRINTING PROCESS AND 3D-PRINTED OBJECT FORMED THEREFROM AND 3D PRINTING PROCESS USING THE SAME | BASF SE (DE) | 2025-07-03 | — | — | US | disclosed |
| US-20250178271-A1 | METHOD FOR TRANSFERRING AN EMBOSSED STRUCTURE TO THE SURFACE OF A COATING AND COMPOUND STRUCTURE CONTAINING SAID COATING | BASF COATINGS GMBH (DE) | 2025-06-05 | — | — | US | disclosed |
| EP-3976344-B1 | METHOD FOR APPLYING EMBOSSED STRUCTURES TO COATING MEDIA WHILE PRE-TREATING THE EMBOSSING TOOL USED THEREFOR | BASF COATINGS GMBH (DE) | 2025-04-30 | — | — | EP | disclosed |
| EP-0897558-A1 | PHOTOSENSITIVE RESIN COMPOSITION FOR RAPID PROTOTYPING AND A PROCESS FOR THE MANUFACTURE OF 3-DIMENSIONAL OBJECTS | DSM N.V. (NL) | 1999-02-24 | — | — | EP | disclosed |
| WO-1998010003-A1 | AQUEOUS DEVELOPABLE PHOTOSENSITIVE POLYURETHANE-METHACRYLATE | POLYFIBRON TECHNOLOGIES, INC. (US) | 1998-03-12 | — | — | WO | disclosed |
| WO-1997042549-A1 | PHOTOSENSITIVE RESIN COMPOSITION FOR RAPID PROTOTYPING AND A PROCESS FOR THE MANUFACTURE OF 3-DIMENSIONAL OBJECTS | DSM N.V. (NL) | 1997-11-13 | — | — | WO | disclosed |
| US-5523443-A | PROTECTIVE COATINGS | CASCHEM, INC. (US) | 1996-06-04 | — | — | US | disclosed |
| US-5426132-A | Alkoxysilyl-urethane acrylate with two curing mechanisms, one activated by exposure to ultraviolet radiation, second by exposure to moisture | CASCHEM, INC. (US) | 1995-06-20 | — | — | US | disclosed |
| US-5312943-A | Protective coatings | CASCHEM, INC. (US) | 1994-05-17 | — | — | US | disclosed |
| US-4222835-A | VINYL MONOMER, PHOTOINITIATOR, THERMAL INITIATOR | WESTINGHOUSE ELECTRIC CORP. (US) | 1980-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559631-B2 | Thermally curable two-component coating compounds | ESD, MGMT, MTHFD2 | SMN1; SMN2 1826/4885GSK3B 2227/4885MEN1 2359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.